U.S. Markets open in 3 hrs, 42 mins
| Symbol | Value | Change | Percentage Change |
|---|---|---|---|
| DJIA | 10,226.94 | 203.52 | 2.03% |
| NASDAQ | 2,154.06 | 41.62 | 1.97% |
| S&P 500 | 1,093.08 | 23.78 | 2.22% |
Experience real-time quotes &
news with the most powerful
iPhone application for investors.
Get the FREE DailyFinance iPhone application
| EPS (TTM): | -0.52 | Current P/E Ratio: | -53.96154 |
|---|---|---|---|
| Last Quarter's Earnings: | 0.58 | Current Quarter Estimate: | 0.57 |
| Last Fiscal Year Earnings: | 0.44 | Next Fiscal Year Estimate: | 2.234 |
| Analyst Consensus: | Underperform | Dividend Rate: | 0.00 |
| Last Dividend: | 0.00 |
First Call Consensus Recommendation Underperform
| Date | Previous Event | Listen | Transcript/Brief |
|---|---|---|---|
| 11/02/2009 | Q3 2009 Valeant Pharmaceuticals International Earnings Conference Call |  |
Download($) |
| 11/02/2009 | Q3 2009 Valeant Pharmaceuticals International Earnings Release | — | — |
| 09/23/2009 | Valeant Pharmaceuticals International at UBS Global Life Sciences Conference | — | Download($) |
| 08/04/2009 | Q2 2009 Valeant Pharmaceuticals International Earnings Conference Call | |
Download($) |
| 08/04/2009 | Q2 2009 Valeant Pharmaceuticals International Earnings Release | — | — |
Notices and Terms: Confirm all data with your broker before trading.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Quote data provided by Interactive Data. Real-Time prices provided by BATS. Historical prices provided by Prophet. Company Profile provided by Hoovers. Executive data and Industry/Sector information provided by Morningstar Inc. Earnings, Ownership, Financial Statement, Insider Trading, Conference Call schedules and SEC Filing information provided by Thomson Reuters.
Advanced Chart
Technical Charts